ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
-1,03%
Bitcoin
62 837,84
6,29%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vor Biopharma Inc (VOR)

  7. Vor Biopharma Inc (VOR) Actualités

VOR Vor Biopharma Inc

1,80
0,04 (2,27%)
Après les heures de négociation
Dernière mise à jour : 00:00:01
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Vor Biopharma Inc VOR NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,04 2,27% 1,80 00:00:01
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,81 1,76 1,84 1,80 1,76
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/5/202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
02/5/202422:01GLOBEVor Bio Appoints Accomplished Oncology and Cancer..
01/4/202414:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
20/3/202421:05GLOBEVor Bio Reports Fourth Quarter and Full Year 2023 Financial..
05/3/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
04/3/202414:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
14/2/202422:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202414:00GLOBEVor Bio to Participate in the Oppenheimer 34th Annual..
02/2/202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
01/2/202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:01GLOBEVor Bio Doses First AML Patient with VCAR33 (ALLO) and..
05/1/202423:03EDGAR2Form 8-K - Current report
21/12/202322:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
01/12/202322:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
27/11/202314:00GLOBEVor Bio to Participate in the JMP Securities Hematology and..
09/11/202322:01GLOBEVor Bio Presents Positive Data Update on Trem-cel at HSCT²..
08/11/202322:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202322:05GLOBEVor Bio Reports Third Quarter 2023 Financial Results and..
07/11/202322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202321:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
03/11/202313:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
02/11/202314:10EDGAR2Form 8-K - Current report
02/11/202314:01GLOBEMultiple Clinical and Preclinical Presentations at ASH..
03/10/202322:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
25/9/202314:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
06/9/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202322:51EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/8/202314:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
10/8/202322:05GLOBEVor Bio Reports Second Quarter 2023 Financial Results and..
10/8/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202314:00GLOBEVor Bio to Participate in the Wedbush PacGrow Healthcare..
09/6/202313:30GLOBESuccessful Primary Engraftment of Trem-cel in First Five AML..
05/6/202314:00GLOBEVor Bio to Participate in the Goldman Sachs Healthcare..
11/5/202322:05GLOBEVor Bio Reports First Quarter 2023 Financial Results and..

Dernières Valeurs Consultées

NASDAQ
VOR
Vor Biopharma
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés